Explore the full record of transactions filed by Jerome CERISIER, Chief Executive Officer. Insider active across 1 companies, notably EXOSENS. Cumulatively, 3 reports have been recorded. Total volume traded: €6m. The latest transaction was disclosed on 17 March 2026 — Cession. Regulator: AMF. All data is openly available.
3 of 3 declarations
Jérôme Cerisier is the Chief Executive Officer of Exosens, a French advanced technology group specializing in amplification, detection and imaging solutions for defense, life sciences, nuclear and industrial control markets. He joined Exosens, formerly Photonis Group, in 2016 to lead the group’s transformation and expansion, and later became its chief executive. His career is rooted in high-technology and defense industries, with a strong international dimension and a clear focus on innovation, industrial scaling and strategic acquisitions. He graduated from École Polytechnique, holds a master’s degree in aeronautics from ISAE-Supaéro, and earned an MBA from INSEAD. He started his career at the French Directorate General of Armaments in 1997, then moved to A.T. Kearney, where he developed strategic consulting expertise, and later joined Gifi Cable / Draka France, where he became executive vice-president in 1996, according to Exosens’ registration document. This combination of elite engineering training, strategy consulting and industrial leadership has shaped a profile well suited to running a technology-intensive company. At Exosens, Cerisier has overseen a period of transformation marked by targeted acquisitions, broader technology coverage and stronger international reach. The company states that it has strengthened its platform through the integration of several businesses since 2022, including Xenics, ProxiVision, Telops and El-Mul, helping it expand into higher-value niche markets and deepen its technological capabilities. He also led Exosens through its listing on Euronext Paris on June 7, 2024, a major milestone that increased the group’s capital-market profile and supported its long-term growth strategy. Under his leadership, Exosens emphasizes profitable growth, industrial capacity expansion and innovation backed by a broad patent portfolio and commercial presence in more than 50 countries. His expertise spans transformation strategy, M&A, industrial execution and the management of sensitive advanced-technology businesses. In a market driven by demand for night-vision, detection and imaging solutions, he has positioned Exosens as a leading European player serving demanding customers in critical environments.